Pharmacokinetic modeling of 4,4'-methylenedianiline released from reused polyurethane dialyzer potting materials

Journal of Biomedical Materials Research

Volumn 53, Issue 3, 2000, Pages 276-286

  Luu, Hoan My Do ^a   Hutter, Joseph C ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

4,4' methylenedianiline; Hemodialyzer; PBPK model; Polyurethane; Reuse

Indexed keywords

4,4' METHYLENEDIANILINE; CARBON 14; POLYURETHAN;

ABSORPTION; ARTICLE; ARTIFICIAL KIDNEY; CALIBRATION; DEGRADATION; DIALYSIS; EXCRETION; HALF LIFE TIME; HYDROLYSIS; KINETICS; METABOLISM; MODEL; OCCUPATIONAL HAZARD; TISSUE;

ANILINE COMPOUNDS; ANIMALS; BIOCOMPATIBLE MATERIALS; CARCINOGENS; EQUIPMENT AND SUPPLIES; HUMANS; MODELS, BIOLOGICAL; POLYURETHANES; RATS;

EID: 0039598890     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(2000)53:3<276::AID-JBM13>3.0.CO;2-E     Document Type: Article

References (25)

1. Shintani H. Formation and elution of toxic compounds from sterilized medical products: Methylene dianiline formation in polyurethane. J Biomater Appl 1995;10:23-58.
2. Hirata N, Matsumoto KI, Inishita T, Takenaka Y, Suma Y, Shintani H. Gamma-ray irradiation, autoclave and ethylene oxide sterilization to thermosetting polyurethane: sterilization to polyurethane. Radiat Phys Chem 1995;46(3):377-381.
3. Rocheleau MJ, Daka J, Hinberg I. Release of 4,4′-methylenedianiline (MDA) and MDA-containing oligomers from polyurethane gastric feeding tubes. Ottawa: 24th Int Symp Envir Anal Chem; 1994. Abs 4P05.
4. Sepai O, Henschler D, Czech S, Eckert P, Sabbioni G. Exposure to toluenediamines from polyurethane-covered breast implants. Toxicol Let 1995;77:371-378.
5. th Ann Meet Soc Biomater; 1994.
6. Nestmann E, Lynch B, Wilson R, Daniels J, Hinberg I, Daka J, Rocheleau MJ. Human health risk assessment of 4,4′-methyledianiline (MDA) released from certain polyurethane medical devices. Toronto: Proc 1996 5th World Biomater Cong Part 2; 1996. p 0529-0602; St Louis: Trans Ann Meet Soc Biomater Int Biomater Symp v.2. Soc Biomater; 1996. p 527.
7. Nestmann E, Lynch B, Wilson R, Daniels J, Hinberg I, Daka J, Rocheleau MJ. Human health risk assessment of 4,4′-methyledianiline (MDA) released from certain polyurethane medical devices. Toronto: Proc 1996 5th World Biomater Cong Part 2; 1996. p 0529-0602; St Louis: Trans Ann Meet Soc Biomater Int Biomater Symp v.2. Soc Biomater; 1996. p 527.
8. Tokars J, Alter, MJ, Favaro MS, Moyer LA, Miller E, Bland LA. National surveillance of dialysis associated diseases in the United States, 1993. ASAIO J 1996;219-229.
9. Kaufman, editor. Introduction to polymer science and engineering: An SPE textbook. New York: Wiley; 1977.
10. Cocker J, Gristwood W, Wilson HK. Assessment of occupational exposure to 4,4′-diaminodiphenylmethane (methylene dianiline) by gas chromatography-mass spectrometry analysis of urine. Br J Ind Med 1986;43(9):620-625.
11. Sepai O, Schutze D, Heinreich U, Henschler D, Sabbioni G. Hemoglobin adducts and urine metabolites of 4,4′-methylendianiline after 4,4′-methylenediphenyl diisocyanate exposure of rats. Chemico-Biol Interact. 1995;97:185-198.
12. Sepai O, Henschler D, Sabbioni G. Albumin adducts and urinary metabolites in workers exposed to 4,4′-methylenediphenyl diisocyanate. Carcinogen 1995;16:2583-2587.
13. Schutze D, Sepai O, Lewalter J, Miksche L, Henschler D, Sabbioni G. Biomonitoring of workers exposed to 4,4′-methylenedianiline or 4,4′-methylenediphenyl diisocyanate. Carcinogen 1995;16(3):573-582.
14. Agency for Toxic Substances and Disease Registry, Center for Disease Control and Prevention, Atlanta, GA. Toxicological profile for methylenedianiline. U.S. Dept. Health & Human Services, Public Health Service; 1998.
15. Occupational Safety and Health Administration. Occupational and Health Standards: Methylenedianiline. US OSHA 29 CFR 1910:1050, 1992.
16. Luu HMD, Hutter JC, Bushar HF. A physiologically based pharmacokinetic model for 2,4-toluenediamine leached from polyurethane foam-covered breast implants. Envir Health Persp 1998;106:393-400.
17. 14C-4, 4′methylenedianiline (4,4′-MDA) in rats, guinea pigs, and monkeys. Govt Rept Announce & Index (GRA & I). 1986; Issue 13.
18. Evans MV, Andersen ME. Sensitivity analysis and the design of gas uptake inhalation studies. Inhal Toxicol 1995;7:1075-1094.
19. Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 1987;13:407-484.
20. Ramsey JR, Anderson ME. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol Appl Pharmacol 1984;73:159-175.
21. Khrisnan K, Andersen ME. Physiologically based pharmacokinetic modeling. In: Hayes AW, editor. Toxicology: principles and methods of toxicology, Third Ed. New York: Raven; 1994. p 149-188.
22. Skarping G, Dalene M, Littorin M. 4,4′-Methylenedianiline in hydrolysed serum and urine from a worker exposed to thermal degradation products of methylene diphenyl diisocyanate elastomers. Int Arch Occup Environ Health 1995;67:73-77.
23. Monro AM. Interspecies comparisons in toxicology: the utilities and futility of plasma concentrations of the test substance. Reg Toxic Pharm 1990;12:137-160.
24. th Ed. Philadelphia: Saunders; 1986.
25. nd Ed. New York: Churchill Livingston; 1991.